Cost-Sharing Limitation for Diabetes Equipment and Supplies
November 08, 2022
Expand ▼
On October 22, 2022, Gov. Carney signed SB 316 into law. The new law prohibits group health plans from imposing a cost-sharing requirement greater than $35 per month per participant for diabetes equipment and supplies. This includes blood glucose meters and strips, urine testing strips, syringes, continuous glucose monitors and supplies, and insulin pump supplies. The $35 monthly maximum applies regardless of the amount or types of supplies and equipment prescribed. The limit applies once the participant’s deductible has been met.
The requirement is effective for policies issued or renewed on or after January 1, 2024. Employers should work with their insurer to make sure that the change is implemented and plan documents are updated.
SB 316 »
Fairness in Cost-Sharing for Prescription Drugs Act
November 08, 2022
Expand ▼
On October 26, 2022, Gov. Carney signed SB 267 into law. The new law requires insurers to include any prescription cost-sharing amount paid by the participant or by another party on behalf of the participant toward the participant’s cost sharing limits under the policy. Cost-sharing requirements include deductible, copayment, coinsurance or out-of-pocket maximum. For example, an amount paid by a drug manufacturer toward a participant’s cost for a prescription would be counted toward the deductible and out-of-pocket maximums. Importantly, if the policy is a qualified high deductible health plan (HDHP), this requirement does not apply until the participant has met the annual statutory HDHP deductible.
The new law is effective for policies issued or renewed on or after January 1, 2024. Employers should work with their carrier to make sure the changes are implemented to the policy and plan documents are revised.
SB 267 »
Coverage Required for Annual Behavioral Health Well Check
September 27, 2022
Expand ▼
On August 3, 2022, Gov. Carney signed HB 303 into law. The new law requires insurers to provide coverage for an annual behavioral health well check, which is defined as:
“A pre-deductible annual visit with a licensed mental health clinician with at minimum a masters level degree. The well check must include but is not limited to a review of medical history, evaluation of adverse childhood experiences, use of a group of developmentally appropriate mental health screening tools, and may include anticipatory behavioral health guidance congruent with stage of life using the diagnosis of annual behavioral health well check.”
The coverage may be limited to participating providers and may be subject to a copayment or coinsurance. The new law is effective January 1, 2024.
HB 303 »
Delaware Enacted Paid Family and Medical Leave Law
May 24, 2022
Expand ▼
On May 10, 2022, Gov. John Carney signed into law the Family and Medical Leave Insurance (FMLI) program called the “Healthy Delaware Families Act.” The payroll withholding of the employees’ contributions is scheduled to begin on January 1, 2025, and the benefits will be available to eligible employees starting January 1, 2026.
There are several key differences from other states’ PFML programs. For example, the minimum employer size that needs to comply with the Delaware FMLI program is an employer who employs 10 or more employees working in Delaware, in contrast to employers with at least one employee working in the state for other states’ PFML programs. Moreover, the Delaware FMLI program allows employers to include their employees who work outside of Delaware to participate in Delaware’s FMLI program voluntarily. Another major difference is employers, rather than the state, are responsible for approving or denying a claim application within five business days of receipt of a completed application with the required documentation. Once approved, the state’s Department of Labor will make the benefits payment to the eligible employees.
Overall, Delaware aligns many of the program’s details and terms with the federal FMLA, such as the definitions of the family members. Therefore, the eligible family members under the FMLI program are much narrower than other states’ PFML programs.
Below are the key highlights of the Delaware FMLI program:
Timeline
- January 1, 2025: Contributions to Family and Medical Leave Insurance Fund begin
- January 1, 2026: Benefits will be available to employees
Covered Employers
- Employers with 10-24 covered employees during the previous 12 months must comply with the parental leave requirements only. Covered employees are those who primarily report to work at a Delaware worksite unless otherwise excluded. However, employers can reclassify an employee as a covered employee even when the EE works at a worksite in another state.
- Employers with 25+ covered employees must comply with all the parental, family caregiving and medical leave requirements.
Funding of the Program
Employers can require covered employees to pay up to 50% of the total premium. Employers are responsible for the remaining premium amount. The contribution amounts in 2025 and 2026 are:
- Parental leave: 0.32% of employee’s wages
- Family caregiving leave: 0.08% of employee’s wages
- Medical leave: 0.4% of employee’s wages
Employers are required to remit the total premium to the state at least quarterly as regulated by the department.
Eligibility to Take Leave
Covered employees are eligible when they have worked at least 1,250 hours over the 12-month period immediately preceding the date on which leave is to begin.
Qualified Reasons for Leave
- EE’s own serious health condition (medical leave)
- For an eligible EE to:
- Care for a family member with a serious health condition (family leave)
- Bond with a new child (by birth, adoption or fostering) during the first 12 months after the child’s birth or placement (parental leave)
- Attend to a qualifying exigency arising out of a family member’s military deployment (family leave)
Maximum Benefits Duration
- Aggregate of all combined leave: 12 weeks total in an application year
- Parental leave: 12 weeks in an application year
- Total family caregiver leave and medical leave: 6 weeks in 24-month period
- Leave can be taken continuously or intermittently or reduced schedule basis only when medically necessary.
Maximum Benefits Amount
Covered employees are entitled to 80% of their average weekly wage up to $900 in 2026 and 2027. (After 2027, revisited annually and adjusted by the state as appropriate.)
Next Steps
Because the contributions do not begin until 2025, and the benefits will be available to eligible employees in 2026, employers have time to review the law closely against their existing leave policies and benefits eligibility, and consider how the new Delaware FMLI will coordinate with other leaves including the federal FMLA and STD. Moreover, employers should monitor any future guidance and developments as it is expected that the state will release more detailed guidance.
Healthy Delaware Families Act »
Coverage for Insulin Pumps
January 04, 2022
Expand ▼
Group health insurance policies issued or renewed after December 31, 2021, must provide coverage for a medically necessary insulin pump at no cost to a covered individual. An insurer may limit the coverage to only those expenses incurred through a network provider.
However, the requirement does not apply to qualified high deductible health plans as such coverage would be considered impermissible and render participants ineligible for HSA contributions. Current IRS guidance provides that insulin, glucometers and hemoglobin A1C testing are considered preventive care and may be covered prior to the statutory HSA deductible, but pumps are not included in that guidance.
Employer plan sponsors should work with their insurers to communicate the coverage change to participants.
SB 107 »
Coverage for Children at High-Risk for Lead Poisoning
January 04, 2022
Expand ▼
Group health insurance policies that provide coverage for outpatient services must provide benefits for lead poisoning screening, testing, diagnostic evaluations, screening/testing supplies and home visits for children who are at risk for lead poisoning. The coverage may be subject to the plan’s normal cost-sharing provisions. The requirement applies to policies issued or renewed after December 31, 2021.
Employer plan sponsors should work with their insurers to communicate the coverage change to participants.
HB 222 »
Coverage for Epinephrine Autoinjectors
July 20, 2021
Expand ▼
On June 15, 2021, Gov. Carney signed HB 95 into law. The new law applies to policies issued or renewed after December 31, 2021. Such policies must provide coverage for medically necessary epinephrine autoinjectors for participants who are 18 years of age or under by including at least one formulation of epinephrine autoinjectors on the lowest tier of the drug formulary developed and maintained by the carrier. Epinephrine autoinjector means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body.
Employers should understand the new coverage and work with carriers to revise and distribute the certificate of coverage to covered employees.
HB 95 »
July 20, 2021
Expand ▼
On June 15, 2021, Gov. Carney signed HB 111 into law. Effective immediately, the new law prohibits life insurance disability policies from discriminating against an individual solely because they have been prescribed pre-exposure prophylaxis medication to prevent HIV infection. Specifically, an insurer cannot refuse to renew, refuse to issue, cancel, restrict coverage or add a premium rating factor based on such fact.
Because of privacy issues, an employer likely will not know if an employee is on such medication. However, the employer should work with insurers to make sure that policies comply and any necessary plan document amendments are made.
HB 111 »
Nondiscrimination Standards in Insurance Expanded
April 27, 2021
Expand ▼
On April 13, 2021, Gov. Carney signed SB 32 into law. The new law, effective immediately, expands the nondiscrimination standards in insurance. Specifically, a carrier may not discriminate in the offer of an insurance policy or the premiums charged based on gender identity or race.
For this purpose, gender identity is defined as a gender-related identity, appearance, expression or behavior of a person, regardless of the person's assigned sex at birth. Gender identity may be demonstrated by consistent and uniform assertion of the gender identity or any other evidence that the gender identity is sincerely held as part of a person's core identity; provided, however, that gender identity shall not be asserted for any improper purpose.
For this purpose, race is expanded to include traits historically associated with race, including hair texture and a protective hairstyle (such as braids, locks and twists).
Insurers and plan sponsors should be aware of these changes to the nondiscrimination standards.
SB 32 »
November 10, 2020
Expand ▼
dThe Department of Insurance has revised and reissued Bulletin No. 86 to clarify coverage requirements related to gender identity. Effective September 4, 2020, health insurance policies are:
- Prohibited from denying, cancelling, terminating, limiting, refusing to issue or renew, or restricting insurance coverage or benefits based on an individual’s gender identity or transgender status
- Prohibited from denying, excluding or limiting coverage for medically necessary services based on the patient’s gender identify if the services are otherwise covered
- Prohibited from containing a blanket exclusion for gender dysphoria, gender identity disorder, medically necessary surgeries or other treatments related to gender transition
- Prohibited from imposing different premiums or rates for insurance coverage based on an insured’s gender identity
This bulletin will govern any fully insured policy issued in Delaware, so plan sponsors should familiarize themselves with these rules.
Bulletin No. 86 »